Liraglutide, A Game-Changer for Effective Weight Loss

Liraglutide is an injectable medication approved for weight loss in adults who are obese or overweight. It is available under the name “Victoza,” and is often prescribed for weight management. Using Liraglutide may help increase feelings of fullness and reduce hunger, further aiding in weight loss.

What is Liraglutide?

Liraglutide is a peptide Discovered by a Danish company, Novo Nordisk in 1990 and is classified under glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used to regulate blood sugar levels. It is a synthetic analog of the naturally occurring hormone GLP-1, with a structure closely resembling the active form of this hormone. Specifically, liraglutide has 31 amino acids and is 97% identical to GLP-1. [1]

By introducing a glutamic acid spacer between the lysine at position 26 and the palmitate group, the structure of Liraglutide is modified. Due to this alteration, the peptide can attach to serum albumin, which delays the kidneys’ elimination and increases its half-life in humans to roughly 13 hours. [2]

It was approved by the FDA in 2010 for the treatment of type 2 diabetes. Later, in 2014, it was also approved for use in adults who are overweight or obese, and by 2020, it received approval for use in adolescents with similar conditions.

Mechanism of Action

Liraglutide functions by activating glucagon-like peptide-1 receptors (GLP-1R) throughout the body, leading to several beneficial effects. In the endocrine pancreas, GLP-1R activation stimulates insulin secretion and suppresses glucagon release, helping to regulate blood sugar levels. [3] In the central nervous system, Liraglutide’s activation of GLP-1R promotes feelings of satiety, reducing overall food intake. [4] Additionally, in the gastrointestinal tract, Liraglutide slows gastric emptying, which further contributes to its effects on appetite control and blood sugar regulation. [5]

Benefits of Liraglutide

Weight Loss

One of the primary and approved uses of Liraglutide is the treatment of overweight and obesity. Numerous clinical trials have shown that Liraglutide can result in significant weight loss among such patients, regardless of whether they have diabetes or not. As of publication, the largest meta-analysis on long-term Liraglutide therapy, which covered over 6,000 participants, revealed that the peptide causes an average weight loss of 4-6%. This meta-analysis included only studies that lasted for more than 12 months, with a Liraglutide dosage of 3mg. [6]

Glycemic Control

Another primary and approved use of Liraglutide is for glycemic control in type 2 diabetes. A systematic review of 43 randomized trials investigated the real-world clinical effectiveness of Liraglutide for the treatment of type 2 diabetes. The review showed that Liraglutide significantly reduces glycated hemoglobin (HbA1c) by 0.9%-2.2% within 6 months of treatment with this peptide. In addition, there was little chance of hypoglycemia with ligliglutide medication, and the positive effects persisted for at least a year. [7]

Increased Insulin Sensitivity

Liraglutide is thought to enhance insulin sensitivity and encourage fatty acid oxidation in insulin-sensitive tissues based on research conducted on animals. Liraglutide exhibits anti-inflammatory properties by lowering hepatic and circulatory cytokine levels. It also causes brown adipocyte differentiation in skeletal muscle. Clinical trials also suggest that Liraglutide may improve insulin sensitivity, but more research is needed. [8]

Neuroprotection

Clinical studies have been conducted to assess the impact of Liraglutide on cerebral glucose uptake, cognitive function, cortical volume, and safety in patients with mild to moderate Alzheimer’s disease. In a Phase 2 trial involving 204 participants with mild Alzheimer’s dementia, subjects were administered either Liraglutide or a placebo for 12 months. The results showed that the group treated with Liraglutide demonstrated significantly improved cognitive function and greater cortical volume than the placebo group. These findings indicate potential neuroprotective effects of Liraglutide, though further research is required to validate these outcomes. [9]

How Much Weight Can You Lose With Liraglutide?

Liraglutide showed significant results when it comes to weight loss. Clinical studies have demonstrated that users can lose between 5–10% of their body weight within a year. However, maintaining this weight loss typically requires additional lifestyle changes, including a healthier diet and increased physical activity. [10]

Side Effects of Liraglutide

Liraglutide can be effective for weight loss and managing diabetes symptoms, but it’s important to be aware of its potential side effects. Common side effects of liraglutide include nausea, diarrhea, vomiting, constipation, abdominal pain, headaches, dizziness, fatigue, and reduced appetite. More severe effects may include gallstones and significant joint pain with swelling in the arms or legs. [11]

While liraglutide can lead to weight loss, this effect may be accompanied by increased blood sugar levels and a higher risk of hypoglycemia (low blood sugar). Before starting liraglutide it’s important to discuss the use of this peptide with your doctor and regularly monitor your blood sugar levels. [11]

It’s important to note that Liraglutide has not been studied for longer than two years, so its long-term safety remains uncertain. Some of the potential, more serious issues can include:

• Pancreatitis (inflammation of the pancreas)
• Gallbladder problems, such as gallstones
• Thyroid cancer or C-cell tumors
• Kidney issues or failure
• Skin rashes or lesions
• Increased risk of hypoglycemia (low blood sugar), especially in type 1 diabetes patients using insulin
• Irregular heartbeats or slow heart rate
• Allergic reactions

The most commonly reported side effect of liraglutide is gastrointestinal discomfort. While insomnia isn’t directly related to Liraglutide, sometimes this gastrointestinal discomfort can affect sleep by making it hard to fall or stay asleep.

It’s also important to consider that liraglutide may interact with other diabetes and obesity medications. Therefore, people taking Liraglutide should consult their doctor before altering their medication regimen to ensure the safe use of all involved medications.

The Dosage

The dosage of liraglutide in research settings varies based on the study’s goals. For weight loss, the maximum recommended dosage is 3 mg/day, though this may be adjusted based on individual tolerance. To minimize side effects, researchers typically start with a lower dose and gradually increase it over five weeks

For comparison, the standard liraglutide dosage for managing type 2 diabetes is 1.2-1.8 mg/day. Research indicates that liraglutide can be used long-term at a dose of 3.0 mg/day. Most dosing protocols in studies last between 20 and 64 weeks, and the medication is generally not cycled. When the dose works well, avoid increasing it. Always target the minimum effective dose, beginning with a low amount and making adjustments slowly. We recommend that starting doses are reduced by 20 to 30% and observe how the peptide affects the body.

Is Liraglutide Safe to Use?

The FDA has approved injectable liraglutide for managing conditions such as type 2 diabetes, overweight, and obesity in individuals aged 12 and older. This approval was based on extensive data from multiple clinical trials demonstrating liraglutide’s safety and effectiveness.

Recent studies confirm that liraglutide is generally well-tolerated among most participants. Using Liraglutide for non-prescription purposes other than those approved by the FDA, such as general weight management, is not advised.

Is Liraglutide Better Than Semaglutide?

Liraglutide and Semaglutide are both injectable peptides used for managing type 2 diabetes, delivered via a prefilled pen. Liraglutide is administered daily, while Semaglutide is given once a week. Both medications are GLP-1 agonists, meaning they mimic the GLP-1 hormone to help regulate blood sugar and reduce appetite, which can support weight loss. Due to different individual responses, it’s hard to tell which one of these peptides is better, they both are effective in treating both diabetes and obesity.

Final Thoughts

Liraglutide is a GLP-1 receptor agonist approved for treating type 2 diabetes and aiding weight loss for people who are obese or overweight. Research indicates that it effectively reduces body weight and enhances glycemic control however it comes with some potential risks. Common side effects include nausea, vomiting, and diarrhea, which typically resolve over time.